# Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia

> **NCT03236805** · PHASE3 · TERMINATED · sponsor: **Nantes University Hospital** · enrollment: 285 (actual)

## Conditions studied

- Pain Management

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT03236805
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-23
- **Primary completion:** 2022-11-26
- **Final completion:** 2022-11-26
- **Target enrollment:** 285 (ACTUAL)
- **Why stopped:** 285 patients have recruited instead on 496 but we don't want to continue to prolonge the study. Analysis will be performed on the data we have.
- **Last updated:** 2022-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03236805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03236805, "Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03236805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*